Ardent announced its board of directors has authorized a share repurchase program of up to $50M. The program will be funded from existing cash resources and does not impact Ardent’s ability to pursue strategic growth opportunities, including mergers and acquisitions, given its strong liquidity position with $609M of cash and a lease-adjusted net leverage of 2.5x as of the end of Q3 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDT:
- Ardent Health price target lowered to $13 from $20 at Mizuho
- Ardent Health price target lowered to $15 from $18 at Guggenheim
- Ardent Health price target lowered to $14.50 from $17 at UBS
- Block upgraded, Dell downgraded: Wall Street’s top analyst calls
- Ardent Health downgraded to Sector Weight from Overweight at KeyBanc